3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Neoplasms
3
Smoking
1
Pulmonary Disease, Chronic Obstructive
1
Pancreatic Neoplasms
1
Neurologic Manifestations
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Lymphoma, Follicular
1
Leukemia, Myeloid, Acute
1
Hyperlipoproteinemia Type II
1
Hematologic Neoplasms
1
Diabetes Mellitus
1
Dementia
1
Colorectal Neoplasms
1
Colitis, Ulcerative
1
Cardiovascular Diseases
1
Carcinoma, Hepatocellular
1
COVID-19
1
Interventions
durvalumab
18
Bevacizumab
17
atezolizumab
13
lenvatinib
10
Magnetic Resonance Spectroscopy
10
tremelimumab
8
Nivolumab
8
pembrolizumab
7
Sorafenib
6
Specimen Handling
5
camrelizumab
4
cabozantinib
4
Immunoglobulin G
4
Disulfides
4
sintilimab
3
apatinib
3
X-Rays
3
Radiotherapy
3
Radiofrequency Ablation
3
Radiation
3
Hepatectomy
3
E-7386
3
Doxorubicin
3
Cyclophosphamide
3
tislelizumab
2
relatlimab
2
dostarlimab
2
budigalimab
2
Standard of Care
2
Simvastatin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Carcinoma, Hepatocellular
×
Atorvastatin
×
Clear all
NCT03024684
2024-11-12
SHOT
Chiayi Christian Hospital
Phase 4
Active not recruiting
240 enrolled